Johnson &Johnson Near Deal for Drugmaker Pharmacyclics -FT
March 04 2015 - 4:53PM
Dow Jones News
Johnson & Johnson (JNJ) is nearing a deal to buy
Pharmacyclics Inc. (PCYC), a developer of cancer treatments, the
Financial Times reported Wednesday on its website, citing people
familiar with the matter.
A deal could be reached in the coming days, although talks could
still fall apart, the people told the FT.
Last month Bloomberg News, citing people with knowledge of the
matter, reported that J&J and Novartis AG (NVS) had shown
interest in buying Pharmacyclics.
Web site: www.ft.com
Write to nymonitoring@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(MM) (NASDAQ:PCYC)
Historical Stock Chart
From Aug 2024 to Sep 2024
(MM) (NASDAQ:PCYC)
Historical Stock Chart
From Sep 2023 to Sep 2024